Gonorrhoea: a systematic review of prevalence reporting globally
J Whelan, V Abbing-Karahagopian, L Serino… - BMC infectious …, 2021 - Springer
Abstract Background The World Health Organization (WHO) recommends periodic
gonorrhoea prevalence assessments in the general population or proxies thereof (including …
gonorrhoea prevalence assessments in the general population or proxies thereof (including …
Functional food ingredients for the management of obesity and associated co-morbidities–A review
RK Baboota, M Bishnoi, P Ambalam… - Journal of Functional …, 2013 - Elsevier
Worldwide obesity has reached a pandemic proportion. World Health Organization (WHO)
estimates that by 2020, two thirds of the global disease burden will be attributable to obesity …
estimates that by 2020, two thirds of the global disease burden will be attributable to obesity …
Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK–p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis
Incidence of hepatocellular carcinoma (HCC) is dramatically increasing and is the third
cause of cancer death worldwide. One key approach to control HCC is chemoprevention by …
cause of cancer death worldwide. One key approach to control HCC is chemoprevention by …
In silico and in vitro analysis of PPAR–α/γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat
Obesity is an abnormal fat accumulation disorder in the metabolic syndrome constellation,
and a risk factor for diabetes, cardiovascular disorders, non-alcoholic fatty liver disease …
and a risk factor for diabetes, cardiovascular disorders, non-alcoholic fatty liver disease …
Purple corn silk: A potential anti-obesity agent with inhibition on adipogenesis and induction on lipolysis and apoptosis in adipocytes
R Chaiittianan, K Sutthanut… - Journal of …, 2017 - Elsevier
Ethnopharmacological relevance Corn silk or the stigma of Zea mays L. has traditionally
been used in weight loss stimulation and treatment of cystitis, urinary infections and obesity …
been used in weight loss stimulation and treatment of cystitis, urinary infections and obesity …
[HTML][HTML] Bioactive compounds in childhood obesity and associated metabolic complications: Current evidence, controversies and perspectives
G Fiore, MC Pascuzzi, E Di Profio, A Corsello… - Pharmacological …, 2023 - Elsevier
Obesity represents the most frequent chronic disease among children worldwide, with a
significant global burden on society. Metabolically unhealthy obesity (MUO) can affect …
significant global burden on society. Metabolically unhealthy obesity (MUO) can affect …
Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease
The current study elucidates pharmacological evaluation of bromelain as a bioactive
compound obtain from pineapple stem belongs to family Bromeliaceae in AlCl 3 and D …
compound obtain from pineapple stem belongs to family Bromeliaceae in AlCl 3 and D …
Unraveling the rationale and conducting a comprehensive assessment of KD025 (Belumosudil) as a candidate drug for inhibiting adipogenic differentiation—a …
SM Barbalho, R de Alvares Goulart, G Minniti… - Naunyn-Schmiedeberg's …, 2024 - Springer
Rho-associated kinases (ROCKs) are crucial during the adipocyte differentiation process.
KD025 (Belumosudil) is a newly developed inhibitor that selectively targets ROCK2. It has …
KD025 (Belumosudil) is a newly developed inhibitor that selectively targets ROCK2. It has …
Regulation of obesity and metabolic complications by gamma and delta tocotrienols
Tocotrienols (T3s) are a subclass of unsaturated vitamin E that have been extensively
studied for their anti-proliferative, anti-oxidative and anti-inflammatory properties in …
studied for their anti-proliferative, anti-oxidative and anti-inflammatory properties in …
Effects of the selective EP2 receptor agonist omidenepag on adipocyte differentiation in 3T3-L1 cells
Y Yamamoto, T Taniguchi, T Inazumi… - Journal of Ocular …, 2020 - liebertpub.com
Purpose: We aimed at comparing the effects of omidenepag (OMD) with those of
prostaglandin F (FP) receptor agonists (FP agonists) on adipogenesis in mouse 3T3-L1 …
prostaglandin F (FP) receptor agonists (FP agonists) on adipogenesis in mouse 3T3-L1 …